“A Prospective, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination Of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s90. Accessed April 17, 2025. https://skin.dermsquared.com/skin/article/view/1060.